Adenovirus mediated IL-24 gene expression inhibits growth of human glioma cell in vitro

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 25, Issue 2, 2009, Pages 279-286

  Shan, Yunbo ^a   Sheng, Weihua ^a   Xie, Yufeng ^a   Liu, Tielian ^a   Jing, Yingying ^a   Hu, Zhiqing ^a   Yang, Jicheng ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Adenovirus; Apoptosis; Gene therapy; Interleukin 24

Indexed keywords

ADENOVIRIDAE;

INTERLEUKIN 24; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24;

ADENOVIRUS; APOPTOSIS; ARTICLE; BRAIN TUMOR; CELL PROLIFERATION; DRUG EFFECT; GENE THERAPY; GENETIC RECOMBINATION; GENETICS; GLIOMA; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE;

ADENOVIRIDAE; APOPTOSIS; BRAIN NEOPLASMS; CELL PROLIFERATION; GENE THERAPY; GLIOMA; HUMANS; INTERLEUKINS; RECOMBINATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 75349087907     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Jiang H, Lin JJ, Su ZZ, et al. Subtraction hybridization identifies a novel melanoma differentiation associated gene, med-7, modulated during human melanoma differentiation, growth and progression. Oncogene, 1995, 11(12): 2477-2486.
2. CaudellE G, Mumm JB, Poindexter N, et al. The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24. J Immunol, 2002, 168(12): 6041-6046.
3. Lebedeva IV, emdad L, Su ZZ, et al. mda-7/IL-24, novel anticancer cytokine: Focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience. Int J Oncol, 2007, 31(5): 985-1007
4. Huang EY, Madireddi MT, Fisher PB, et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene, 2001, 20(48): 7051-7063.
5. Castro MG, Cowen R, Williamson IK, et al. Current and future strategies for the treatment of malignant brain tumors. Pharmacol Ther, 2003, 98(1): 71-108.
6. Phuong LK, Allen C, Peng KW, et al. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiform. Cancer Res, 2003, 63(10): 2462-2469.
7. Xie YF, Sheng WH, Yang JC, et al. Recombinant human IL-24 suppresses lung carcinoma cell growth via induction of cell apoptosis and inhibition of tumor angiogenesis. Cancer Biother Radio, 2008, 23(3): 310-320.
8. Zhao XY, Sheng WH, Yang JC, et al. The tumorsuppressing effects of rhIL-24 protein on B16 cells in vitro and in vivo. Jiangsu Med J, 2006, 32(12): 1125-1128.
9. Yan S, Xie XF, Yang JC, et al. Study of effects of rhIL-24 on the growth gastric cancer cell line in vitro and its mechanism. Suzhou University J Med Sci, 2006, 26(3): 370-374.
10. Wang XH, Wang JZ, Yang JC, et al. The study of the growth-suppression and mechanisms of Hepatocelluar carcinoma tumor in nude Mice. Chin J Biotech, 2006, 22(6): 925-930.
11. Yan S, Yang JC, Cheng WC, et al. Growth-suppression of rhIL-24 on gastric cancer in nude mice. Chin J Digest, 2007, 27(8): 555-556.
12. Wei SH, Sheng WH, Yang JC, et al. Immunostimulation and depressant effects of rhIL-24 protein on angiopoiesis in vitro. JiangSu Med J, 2007, 33(3): 273-276.
13. Zhu YH, Ye ZM, Yang JC, et al. Study of effects of rhIL-24 on the growth and angiogenesis of lung cancer A549 cell in vitro. Chin J Tuberc Respir Dis, 2006, 29(3): 203-205.
14. Pan XT, Sheng WH, Yang JC, et al. Inhibition of pancreatic carcinoma growth by adenovirus-mediated human interleukin-24 expression in animal model. Cancer Biother Radio, 2008, 23(4): 425-434.
15. He TC, Zhou S, Da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA, 1998, 95(5): 2509-2514.
16. Ye ZM, Zhang SW, Miao JC, et al. The Construction and identification of recombinant adenovirus vector of hIL-24. Suzhou Univ J Med Sci, 2006, 26(1): 44-46.
17. Yuan YT, Wang ZH, Sun XW, et al. Effects of interleukin-24 on the cytotoxic activity cytokine-induced killer cells. World Chin J Digestol, 2007, 15(6): 548-553.
18. Zhang Zb, Liang JQ, Yuan YT, et al. IL-24 enhances the cytotoxic activity of CIK cell against HepG2 cell. J Harbin Med Univ, 2007, 41(5): 418-421.
19. Sainz-Perez A, Gary-Gouy H, Dalloul A, et al. IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression. J Immunol, 2008, 181(9): 6051-6060.
20. Sarkar D, Lebedeva IV, Gupta P, et al. Melanoma differentiation associated gene-7 (mda-7)/IL-24: a magic bullet for cancer therapy? Expert Opin Biol Th, 2007, 7(5): 577-586.
21. Miura M. Ice/ced-3 family gene and apoptosis. Jap J Clin Med, 1996, 54(7): 1860-1868
22. Robson S, Pelengaris S, Khan M. c-Myc and downstream targets in the pathogenesis and treatment of cancer. Rec Patents Anti-Cancer Drug Disc, 2006, 1(3): 305-326.
23. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via denovoprotein synthesis binds to the human erythropoietin gene enhance ratasite required fortranscriptional activation. Mol Cell Biol, 1992, 12(12): 5447-5456.
24. Kunz M, Ibrahim SM. Molecular responses to hypoxia in tunlor cells. J Mol Cancer, 2003, 2(1): 19-23.
25. Duff JP, Eibl G, Reber HA, et al. Influence of hypoxia and neoangiogenesis on the growth ofpancreatic cancer. J Mol Cancer, 2003, 2(5): 12-22.
26. Yu RT, Chen R, Tang H, et al. Hammerhead ribozyme targeting human hypoxia inducible factor-1α gene effectively attenuates HeLa xenograft tumors. Surg Neurol, 2008, 7(3): 56-65.
27. Sun X, Kanwar JR, Leung E, et al. Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy. Gene Ther, 2001, 8(8): 638-645.
28. Sun X, Kanwar JR, Leung E, et al. Regression of solid tumors by engineered overexpression of von Hippel-Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1alpha. Gene Ther, 2003, 10(7): 2081-2089.
29. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 2003, 3(10): 721-732.